Our Mission
IMPROVING PATIENT SAFETY WITH
HIGH-VALUE DRUG SECURITY DEVICES.
For over 50 years, IMI has manufactured high-quality medical devices that meet the unique needs
of compounding pharmacies and enhance medication safety from pharmacy to patient.
About Us
International Medical Industries (IMI) has been at the forefront of medical device innovation for over 50 years. Specializing in the design, development, and manufacturing of both sterile and non-sterile single-use medical devices, IMI has become synonymous with excellence and reliability in the healthcare industry. Our primary focus lies in providing cutting-edge tamper-evident technologies, which serve as a crucial deterrent against drug diversion and misuse. These technologies are integral components of healthcare systems’ comprehensive drug security programs, ensuring patient safety and regulatory compliance.
IMI is widely recognized as the market leader in tamper-evident technology, with our flagship product, Prep-Lock™ Tamper Evident Caps for I.V. Syringes, leading the industry. These caps seal the distal end of syringes securely, safeguarding medication integrity during transit from the pharmacy to the patient’s bedside. In addition to our flagship product, IMI offers a diverse range of sterile single-use devices tailored for pharmacy use. This includes Prep-Lock™ Tamper Evident Additive Port Caps for I.V. bags, Prep-Seal™ Luer Lock Caps essential closures for syringes, Prep-Fill™ fluid transfer connectors, and the Rx-Tract and Rx-Vent lines of specialty needles.
All IMI products are proudly designed and manufactured in the USA at our state-of-the-art facility in Pompano Beach, FL. Committed to maintaining the highest quality standards, IMI is registered with the FDA and holds ISO 13485 certification, ensuring that our products meet rigorous regulatory requirements and exceed customer expectations.
With a steadfast dedication to innovation, quality, and patient safety, IMI continues to lead the way in providing healthcare professionals with the tools they need to deliver superior care and ensure the integrity of medication delivery systems.
The History of IMI
From its humble beginnings, International Medical Industries burgeoned into an esteemed name known for innovation and customer-centric solutions. Through unwavering commitment to intellectual property, research, development, and collaboration, IMI became a trusted partner for healthcare providers, institutions, and pharmacists worldwide.
As International Medical Industries looks to the future, it remains dedicated to shaping the landscape of healthcare. Positioned at the forefront of technological advancements and evolving healthcare needs, IMI is poised to lead the charge in improving pharmacy compounding practices and medication safety. With a relentless focus on innovation, quality, and medication security, the company is committed to expanding its global presence and driving transformative solutions to address the most pressing challenges facing health system pharmacies worldwide. Through strategic partnerships, investments in research and development, and a steadfast dedication to its core values and employees, IMI is primed to continue its legacy of excellence for years to come.
IMI’s success is strengthened by experienced leadership, including Senior Vice President of Operations, Susan Vitello, whose cross-functional management and customer-focused leadership have elevated operational performance and driven sustained customer satisfaction. Her commitment to championing the “voice of the customer” continues to inform IMI’s strategy and service delivery. Learn more about IMI’s executive team below.
OUR COMMITMENT TO SUSTAINABILITY
As a global plastic-processing medical technology company, IMI is committed to minimizing plastic waste and reducing its environmental impact. IMI recognizes sustainability as an important value proposition to reduce its environmental footprint.
IMI TEAM LEADERS
Jonathan Vitello
President
Jon Vitello has over 30 years of progressive management experience, including key product development roles with IBM. His acquisition of IMI in 1993 had an immediate and positive impact on the direction of the organization . As a strategist and accessible leader, Jon is known for driving GROWTH AND PROFITABILITY with expertise developing and delivering technology solutions for hospitals, health systems and drug compounding outsourcers.
Jacqueline Vitello
Jacqueline Vitello is the Chief Operating Officer at International Medical Industries, previously serving as Director of Business Strategy. With leadership experience in both government and private sectors, she drives organizational advancement through innovative technologies and strategic operations. Jacqueline holds an Executive MBA from FAU and advanced degrees in International Security and Chemical Science. Her background includes leadership at the U.S. Department of Commerce and co-founding the China Power Project at the Center for Strategic and International Studies.
Virginia Mateo
Chief Financial Officer
Virginia Mateo has over 20 years of robust experience in financial portfolio management. She has a proven track record of creating and implementing corporate practices and policies that consistently generate profitable results. Over the years, she has successfully executed her operational decision-making prowess to bring financial gains to firms from the hospitality, real estate, and entertainment sectors. Virginia is an accredited, detail orientated leader with a noteworthy history of harmonizing legal, insurance, finance, and sales teams around best practices to ensure the organization’s long-term health.
Bryan McGurn
Senior Vice President, Sales & Marketing
Bryan McGurn has over 30 years’ experience in the medical device field. Prior to his position as VP Sales & Marketing, Bryan held a number of key roles in executive and general management with P&L responsibility. Throughout his career, he has made a mark in orchestrating countless revenue generating sales programs and marketing campaigns that clearly articulate product benefits and organizational strengths. His previous management tenures include companies such as American Hydro-Surgical, Nipro Corporation, and Medtronic MiniMed.
Tony Delamaza
Vice President, Business Development
Tony Delemaza brings over 25 years of experience in the fields of medical device, biologics and cellular therapy to IMI. Prior to joining the team as the VP of Sales & Business development, he held various positions in general and executive management with multi-national companies including DaVinci Biosciences, Nipro Corporation, and Medtronic MiniMed. Tony is an accomplished leader with expertise in developing Sales, Clinical, and Customer Service teams to drive revenue growth while introducing state-of-the-art therapies to enhance clinical outcomes.
Our Distribution Partners
Our International Partners
